๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The replacement of the replacement in menopause: hormone therapy, controversies, truth and risk

โœ Scribed by Beverley A. Burrell

Book ID
108961385
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
192 KB
Volume
16
Category
Article
ISSN
1320-7881

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hormone replacement therapy and lung can
Hormone replacement therapy and lung cancer risk in Chinese
โœ Kuan-Yu Chen; Chin-Fu Hsiao; Gee-Chen Chang; Yin-Huang Tsai; Wu-Chou Su; Reury-P ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 100 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. The association between hormone replacement therapy (HRT) and a reduced lung cancer risk has been reported in previous studies. There is a high female to male ratio in Chinese lung cancer patients, and female patients have different clinicopathological characteristics co

Cyclic hormonal replacement therapy afte
Cyclic hormonal replacement therapy after the menopause: Transdermal versus oral treatment
โœ M. Cortellaro; T. Nencioni; C. Boschetti; S. Ortolani; F. Buzzi; B. Francucci; M ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 566 KB

In an open, randomized, comparative, between-patient trial, 45 postmenopausal women were treated for 4 months with cyclical transdermal oestradiol 0.05 mg per day or oral conjugated equine oestrogens 0.625 mg per day, in both cases, plus, medroxyprogesterone acetate 10 mg per day on the last 8 days